Atlas Trials

Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)

Clinical trial NCT03369743 · COMPLETED

Trial details

NCT number
NCT03369743
Sponsor
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Status
COMPLETED
Study type
OBSERVATIONAL
HIV Infections
Start date
2018-01-02
Primary completion
2018-06-30
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.